$18.83
-1.08-5.42%
al cierre: -
Comments
Loading...
iShares Genomics Immunology and Healthcare ETF
IDNAARCA
Sector
Healthcare
Region
US
AUM
105.81M
Fund Score
iShares Genomics Immunology and Healthcare ETF (ARCA:IDNA) Cotizaciones y resumen de noticias
iShares Genomics Immunology and Healthcare ETF (ARCA: IDNA) cotización, noticias, gráficos, investigación bursátil, perfil.
| Apertura | $19.41 |
| Máximo | $19.43 |
| Máximo de 52 semanas | $25.80 |
| AUM | 105.81M |
| Dividendo | $0.26 |
| Fecha Ex-Div | dic 17, 2024 |
| Volumen | 29.43K |
| Capitalización bursátil | $25.90B |
| Tarifa de gestión | 0.47% |
| Ratio PER | 20.66 |
| Cierre anterior | $19.91 |
| Mínimo | $18.81 |
| Mínimo de 52 semanas | $19.77 |
| Acciones en circulación | 5.85M |
| Rendimiento | 1.39% |
| Frec. de Div. | S |
| Promedio Volumen diario | 36.32K |
| Beta | 1.11 |
| Promedio Relación de gastos | 0.47% |
| Relación P/B | 2.92 |
Noticias recientes
PREGUNTAS FRECUENTES
Q
¿Cómo puedo comprar la acción de iShares Genomics Immunology and Healthcare ETF (IDNA)?
A
Puedes comprar acciones de iShares Genomics Immunology and Healthcare ETF (ARCA:IDNA) a través de cualquier corretaje en línea.
Q
¿Quiénes son los competidores de iShares Genomics Immunology and Healthcare ETF (IDNA)?
A
No hay competidores como tal para iShares Genomics Immunology and Healthcare ETF.
Q
¿Cuál es el pronóstico o precio objetivo para las acciones de iShares Genomics Immunology and Healthcare ETF (IDNA)?
A
No existe ningún análisis de iShares Genomics Immunology and Healthcare ETF que proporcione un precio objetivo de consenso.
Q
¿Cuál es el precio actual de las acciones de iShares Genomics Immunology and Healthcare ETF (IDNA)?
A
El precio de las acciones de iShares Genomics Immunology and Healthcare ETF (ARCA: IDNA) es de 18.83 dólares, actualizado por última vez el 4 de abril de 2025, 20:00 GMT-4.
Q
¿iShares Genomics Immunology and Healthcare ETF (IDNA) paga dividendos?
A
No hay dividendos previstos para iShares Genomics Immunology and Healthcare ETF.
Q
¿Cuándo iShares Genomics Immunology and Healthcare ETF (ARCA:IDNA) publicará los resultados?
A
No hay informes de resultados previstos para iShares Genomics Immunology and Healthcare ETF.
Q
¿iShares Genomics Immunology and Healthcare ETF (IDNA) se va a dividir?
A
No hay ninguna división de acciones prevista para iShares Genomics Immunology and Healthcare ETF.
| Apertura | $19.41 |
| Máximo | $19.43 |
| Máximo de 52 semanas | $25.80 |
| AUM | 105.81M |
| Dividendo | $0.26 |
| Fecha Ex-Div | dic 17, 2024 |
| Volumen | 29.43K |
| Capitalización bursátil | $25.90B |
| Tarifa de gestión | 0.47% |
| Ratio PER | 20.66 |
| Cierre anterior | $19.91 |
| Mínimo | $18.81 |
| Mínimo de 52 semanas | $19.77 |
| Acciones en circulación | 5.85M |
| Rendimiento | 1.39% |
| Frec. de Div. | S |
| Promedio Volumen diario | 36.32K |
| Beta | 1.11 |
| Promedio Relación de gastos | 0.47% |
| Relación P/B | 2.92 |
Información sobre iShares Trust
Sector
NULO
Industria
NULO
ETF Details
| Sector | Healthcare |
| Category | High Performer-High Growth |
| Investment Style | Mid Cap Growth |
| Fund Inception | jun 11, 2019 |
| Managers | Paul Whitehead Greg Savage Jennifer Hsui |
| Definition | An equity fund portfolio full of stocks with both strong financial performance and superior growth potential |
Investment Policy
The fund generally will invest at least 90% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 10% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. It is non-diversified.
Top ETF Holdings
| Symbol | Name | Share % |
|---|---|---|
| SM | Roche Holding A.G. | 5.49% |
| GILD | Gilead Sciences Inc | 4.62% |
| SRPT | Sarepta Therapeutics I... | 4.53% |
| RVMD | Revolution Medicines I... | 4.44% |
| INCY | Incyte Corp. | 4.30% |
| REGN | Regeneron Pharmaceutic... | 4.23% |
| EXEL | Exelixis Inc | 5.05% |
| TK | Takeda Pharmaceutical ... | 4.95% |
| PA | Sanofi SA | 5.54% |
| HK | Beigene, Ltd. | 6.57% |
| SWTX | Springworks Therapeuti... | 4.73% |
| LN | GSK plc | 5.40% |
| CO | Genmab A.S. | 4.33% |
| MRK | Merck & Co. Inc. | 4.26% |
SOCIO/CONTRIBUIDOR
© 2025 Benzinga | All Rights Reserved